Patricia Balsas

Barcelona, CT, Spain

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 11 publications

Author Correction: SOX11/PRDX2 axis modulates redox homeostasis and chemoresistance in aggressive mantle cell lymphoma.

Author Correction: SOX11/PRDX2 axis modulates redox homeostasis and chemoresistance in aggressive mantle cell lymphoma.

Journal: Scientific reports
Published: June 11, 2024

SOX11 expression is restricted to EBV-negative Burkitt lymphoma and is associated with molecular genetic features.

SOX11 expression is restricted to EBV-negative Burkitt lymphoma and is associated with molecular genetic features.

Journal: Blood
Published: November 16, 2023

SOX11/PRDX2 axis modulates redox homeostasis and chemoresistance in aggressive mantle cell lymphoma.

SOX11/PRDX2 axis modulates redox homeostasis and chemoresistance in aggressive mantle cell lymphoma.

Journal: Scientific reports
Published: November 10, 2023

Tumorigenic role of Musashi-2 in aggressive mantle cell lymphoma.

Tumorigenic role of Musashi-2 in aggressive mantle cell lymphoma.

Journal: Leukemia
Published: June 01, 2022

SOX11, CD70, and Treg cells configure the tumor-immune microenvironment of aggressive mantle cell lymphoma.

SOX11, CD70, and Treg cells configure the tumor-immune microenvironment of aggressive mantle cell lymphoma.

Journal: Blood
Published: January 13, 2021

SOX11 promotes tumor protective microenvironment interactions through CXCR4 and FAK regulation in mantle cell lymphoma.

SOX11 promotes tumor protective microenvironment interactions through CXCR4 and FAK regulation in mantle cell lymphoma.

Journal: Blood
Published: April 05, 2017

Activity of the novel BCR kinase inhibitor IQS019 in preclinical models of B-cell non-Hodgkin lymphoma.

Activity of the novel BCR kinase inhibitor IQS019 in preclinical models of B-cell non-Hodgkin lymphoma.

Journal: Journal of hematology & oncology
Published: December 29, 2016

SOX11 defines two different subtypes of mantle cell lymphoma through transcriptional regulation of BCL6.

SOX11 defines two different subtypes of mantle cell lymphoma through transcriptional regulation of BCL6.

Journal: Leukemia
Published: December 30, 2015

Disruption of follicular dendritic cells-follicular lymphoma cross-talk by the pan-PI3K inhibitor BKM120 (Buparlisib).

Disruption of follicular dendritic cells-follicular lymphoma cross-talk by the pan-PI3K inhibitor BKM120 (Buparlisib).

Journal: Clinical cancer research : an official journal of the American Association for Cancer Research
Published: May 07, 2014

4-Amino-2-arylamino-6-(2,6-dichlorophenyl)-pyrido[2,3-d]pyrimidin-7-(8H)-ones as BCR kinase inhibitors for B lymphoid malignancies.

4-Amino-2-arylamino-6-(2,6-dichlorophenyl)-pyrido[2,3-d]pyrimidin-7-(8H)-ones as BCR kinase inhibitors for B lymphoid malignancies.

Journal: European journal of medicinal chemistry
Published: April 10, 2014

Synergistic antitumor activity of lenalidomide with the BET bromodomain inhibitor CPI203 in bortezomib-resistant mantle cell lymphoma.

Synergistic antitumor activity of lenalidomide with the BET bromodomain inhibitor CPI203 in bortezomib-resistant mantle cell lymphoma.

Journal: Leukemia
Published: January 02, 2014
Showing 1-11 of 11

Last Updated: 09/26/2026